Enzastaurin (ENZ) versus lomustine (CCNU) in the treatment of recurrent, intracranial glioblastoma multiforme (GBM): A phase III study

被引：17
|
作者：
Fine, H. A.
Puduvalli, V. K.
Chamberlain, M. C.
Carpentier, A. F.
Cher, L.
Mason, W. P.
van den Bent, M. J.
Hong, S.
Thornton, D.
Wick, W.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Hop La Pitie Salpetriere, Paris, France
[5] Austin Hlth, Heidelberg, Vic, Australia
[6] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[7] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[8] Eli Lilly & Co, Indianapolis, IN 46285 USA
[9] Univ Tubingen, Tubingen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.2005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2005
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei Yin
    Parvataneni, R.
    Hristova-Kazmierski, Maria
    Musib, Luna
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (06) : 608 - 613
  • [32] Phase II Study of Lonidamine and Diazepam in the Treatment of Recurrent Glioblastoma Multiforme
    Stéphane Oudard
    Antoine Carpentier
    Eugeniu Banu
    François Fauchon
    Denis Celerier
    Marie F. Poupon
    Bernard Dutrillaux
    Jean M. Andrieu
    Jean Y. Delattre
    Journal of Neuro-Oncology, 2003, 63 : 81 - 86
  • [33] Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme
    Badruddoja, Michael A.
    Penne, Kara
    Desjardins, Annick
    Reardon, David A.
    Rich, Jeremy N.
    Quinn, Jennifer A.
    Sathornsumetee, Sith
    Friedman, Allan H.
    Bigner, Darell D.
    Herndon, James E., II
    Cahill, Ann
    Friedman, Henry S.
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2007, 9 (01) : 70 - 74
  • [34] Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme
    Oudard, S
    Carpentier, A
    Banu, E
    Fauchon, F
    Celerier, D
    Poupon, MF
    Dutrillaux, B
    Andrieu, JM
    Delattre, JY
    JOURNAL OF NEURO-ONCOLOGY, 2003, 63 (01) : 81 - 86
  • [35] NCCTG phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM).
    Galanis, E
    Buckner, JC
    Maurer, M
    Ballman, K
    Hidalgo, M
    Kreisberg, JI
    Boni, J
    James, CDD
    Jenkins, RB
    Walsh, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 107S - 107S
  • [36] Treatment of recurrent anaplastic astrocytoma (AA) and glioblastoma multiforme (GBM) with the glutamate antagonist riluzole
    Das, A
    Learn, J
    Le, MT
    Yu, J
    Pikul, B
    Black, K
    NEURO-ONCOLOGY, 2004, 6 (04) : 373 - 373
  • [37] Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide
    Paulsen, F
    Hoffmann, W
    Becker, G
    Belka, C
    Weinmann, M
    Classen, J
    Kortmann, RD
    Bamberg, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (07) : 411 - 418
  • [38] Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide
    Frank Paulsen
    Wolfgang Hoffmann
    Gerd Becker
    Claus Belka
    Martin Weinmann
    Johannes Classen
    Rolf-Dieter Kortmann
    Michael Bamberg
    Journal of Cancer Research and Clinical Oncology, 1999, 125 : 411 - 418
  • [39] A PHASE II TRIAL OF SUNITINIB IN THE TREATMENT OF RECURRENT GLIOBLASTOMA (GBM)
    Kreisl, Teri N.
    Smith, P.
    Iwamoto, Fabio
    Sul, Joohee
    Butman, John A.
    Fine, Howard A.
    NEURO-ONCOLOGY, 2010, 12 : 71 - 72
  • [40] Phase I/II study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Thornton, D.
    DeBoer, R.
    Page, M.
    Rabbitt, J.
    Parvanateni, R.
    Kivett, V.
    Nicol, S.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345